Journal of Mass Spectrometry · 1992 · 49 citations · 16 references
PharmacyPharmaceutical AnalysisPharmacologyAnalytical ChemistryChromatographic AnalysisMass Spectrometric AnalysisAnalytical ChromatographyBioanalytical Method ValidationChromatographyInstrumental AnalysisLiquid ChromatographyMass Spectrometry5 Alpha-reductase5-Alpha-reductase InhibitionAssayHigh-performance Liquid Chromatography Method DevelopmentHigh-performance Liquid Chromatography-mass SpectrometryLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisLiquid Chromatography-mass Spectrometry Method Development
L-654,066 is a new 5 alpha-reductase inhibitor. A sensitive and specific assay based on combined liquid chromatography/mass spectrometry has been developed for the determination of this drug candidate in plasma. The analyte was isolated from plasma by solid-phase extraction on a C-18 cartridge. A related substance, L-683,838, was used as the internal standard. Extracts were chromatographed on a 5 cm C18 reverse-phase high-performance liquid chromatography column interfaced via the heated nebulizer probe to a corona discharge chemical ionization source. The mass spectrometer was operated in the positive ion tandem mode. The method has sufficient sensitivity, precision, accuracy and selectivity for the analysis of clinical samples containing L-654,066 at concentrations in the range 0.5-20 ng ml-1. The chromatographic run time is less than 2 min.
16
Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism
Julianne Imperato‐McGinley, Luis Guerrero, Teófilo Gautier et al. · Science · 1974 · 1.3K citations
Selective Retention of Dihydrotestosterone by Prostatic Nuclei
K.M. Anderson, Shutsung Liao · Nature · 1968 · 532 citations
Dihydrotestosterone in prostatic hypertrophy
Pentti K. Siiteri, Jean D. Wilson · Journal of Clinical Investigation · 1970 · 407 citations · Full text
Medicine, Endocrinology, Urology +14